IBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
ITQB NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Biotechnol Bioeng. 2021 Jul;118(7):2536-2547. doi: 10.1002/bit.27766. Epub 2021 Apr 8.
Stable insect cell lines are emerging as an alternative to the insect cell-baculovirus expression vector system (IC-BEVS) for protein expression, benefiting from being a virus-free, nonlytic system. Still, the titers achieved are considerably lower. In this study, stable insect (Sf-9 and High Five) cells producing Gag virus-like particles (VLPs) were first adapted to grow under hypothermic culture conditions (22°C instead of standard 27°C), and then pseudotyped with a model membrane protein (influenza hemagglutinin [HA]) for expression of Gag-HA VLPs. Adaptation to lower temperature led to an increase in protein titers of up to 12-fold for p24 (as proxy for Gag-VLP) and sixfold for HA, with adapted Sf-9 cells outperforming High Five cells. Resulting Gag-HA VLPs producer Sf-9 cells were cultured to high cell densities, that is, 100 × 10 cell/ml, using perfusion (ATF® 2) in 1 L stirred-tank bioreactors. Specific p24 and HA production rates were similar to those of batch culture, enabling to increase volumetric titers by 7-8-fold without compromising the assembly of Gag-HA VLPs. Importantly, the antigen (HA) quantity in VLPs generated using stable adapted cells in perfusion was ≈5-fold higher than that from IC-BEVS, with the added benefit of being a baculovirus-free system. This study demonstrates the potential of combining stable expression in insect cells adapted to hypothermic culture conditions with perfusion for improving Gag-HA VLPs production.
稳定昆虫细胞系正作为一种替代昆虫细胞-杆状病毒表达载体系统(IC-BEVS)的方法而出现,用于蛋白质表达,其优势在于无病毒、非裂解系统。然而,所达到的效价仍然低得多。在本研究中,首先使生产 Gag 病毒样颗粒(VLPs)的稳定昆虫(Sf-9 和 High Five)细胞适应于低温培养条件(22°C 而不是标准 27°C),然后用模型膜蛋白(流感血凝素[HA])假型化以表达 Gag-HA VLPs。适应较低温度导致 p24(作为 Gag-VLP 的替代物)的蛋白效价增加高达 12 倍,HA 增加 6 倍,适应的 Sf-9 细胞优于 High Five 细胞。所得的 Gag-HA VLP 生产 Sf-9 细胞使用灌注(ATF® 2)在 1L 搅拌罐生物反应器中培养至高细胞密度,即 100×10^6 细胞/ml。特异性 p24 和 HA 生产速率与分批培养相似,能够在不影响 Gag-HA VLPs 组装的情况下将体积效价提高 7-8 倍。重要的是,在灌注中使用适应低温培养条件的稳定细胞生成的 VLPs 中的抗原(HA)量比 IC-BEVS 高约 5 倍,并且具有无杆状病毒系统的额外优势。本研究表明,将适应低温培养条件的昆虫细胞中的稳定表达与灌注相结合用于提高 Gag-HA VLPs 生产的潜力。